-
1
-
-
0037160782
-
The muscular dystrophies
-
Emery AEH. The muscular dystrophies. Lancet 2002;359:687-695.
-
(2002)
Lancet
, vol.359
, pp. 687-695
-
-
Emery, A.E.H.1
-
2
-
-
0023614188
-
Dystrophin-the protein product of the Duchenne muscular-dystrophy locus
-
Hoffman EP, Brown RH, Kunkel LM. Dystrophin-the protein product of the Duchenne muscular-dystrophy locus. Cell 1987;51:919-928.
-
(1987)
Cell
, vol.51
, pp. 919-928
-
-
Hoffman, E.P.1
Brown, R.H.2
Kunkel, L.M.3
-
3
-
-
0027460658
-
Dystrophin protects the sarcolemma from stresses developed during muscle contraction
-
Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 1993;90:3710-3714.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 3710-3714
-
-
Petrof, B.J.1
Shrager, J.B.2
Stedman, H.H.3
Kelly, A.M.4
Sweeney, H.L.5
-
5
-
-
27644488152
-
The multidisciplinary management of Duchenne muscular dystrophy
-
Bushby K, Bourke J, Bullock R, Eagle M, Gibson M, Quinby J. The multidisciplinary management of Duchenne muscular dystrophy. Curr Paediatr 2005;15:292-300.
-
(2005)
Curr Paediatr
, vol.15
, pp. 292-300
-
-
Bushby, K.1
Bourke, J.2
Bullock, R.3
Eagle, M.4
Gibson, M.5
Quinby, J.6
-
6
-
-
36249019783
-
New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials
-
Cossu G, Sampaolesi M. New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. Trends Mol Med 2007;13:520-526.
-
(2007)
Trends Mol Med
, vol.13
, pp. 520-526
-
-
Cossu, G.1
Sampaolesi, M.2
-
7
-
-
34648854432
-
Genetic treatments in muscular dystrophies
-
Muntoni F, Wells D. Genetic treatments in muscular dystrophies. Curr Opin Neurol 2007;20:590-594.
-
(2007)
Curr Opin Neurol
, vol.20
, pp. 590-594
-
-
Muntoni, F.1
Wells, D.2
-
8
-
-
84876483438
-
Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy
-
Fischmann A, Hafner P, Gloor M, Schmid M, Klein A, Pohlman U, et al. Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy. J Neurol 2013;260:969-974.
-
(2013)
J Neurol
, vol.260
, pp. 969-974
-
-
Fischmann, A.1
Hafner, P.2
Gloor, M.3
Schmid, M.4
Klein, A.5
Pohlman, U.6
-
9
-
-
84863980950
-
Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments
-
Gaeta M, Messina S, Mileto A, Vita GL, Ascenti G, Vinci S, et al. Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Skelet Radiol 2012;41:955-961.
-
(2012)
Skelet Radiol
, vol.41
, pp. 955-961
-
-
Gaeta, M.1
Messina, S.2
Mileto, A.3
Vita, G.L.4
Ascenti, G.5
Vinci, S.6
-
10
-
-
38449096326
-
Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study
-
Wren TAL, Bluml S, Tseng-Ong L, Gilsanz V. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. Am J Roentgenol 2008;190:W8-12.
-
(2008)
Am J Roentgenol
, vol.190
-
-
Wren, T.A.L.1
Bluml, S.2
Tseng-Ong, L.3
Gilsanz, V.4
-
11
-
-
4344588135
-
-
The Netherlands. Neuromuscul Disord
-
Bushby K, Muntoni F, Urtizberea A, Hughes R, Griggs R. Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids. 2-4 April 2004, Naarden, The Netherlands. Neuromuscul Disord 2004;14:526-534.
-
(2004)
Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids. 2-4 April 2004, Naarden
, vol.14
, pp. 526-534
-
-
Bushby, K.1
Muntoni, F.2
Urtizberea, A.3
Hughes, R.4
Griggs, R.5
-
12
-
-
0034431849
-
Stereotaxic display of brain lesions
-
Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol 2000;12:191-200.
-
(2000)
Behav Neurol
, vol.12
, pp. 191-200
-
-
Rorden, C.1
Brett, M.2
-
13
-
-
70350469122
-
MR imaging in Duchenne muscular dystrophy: quantification of t-1-weighted signal, contrast uptake, and the effects of exercise
-
Garrood P, Hollingsworth KG, Eagle M, Aribisala BS, Birchall D, Bushby K, et al. MR imaging in Duchenne muscular dystrophy: quantification of t-1-weighted signal, contrast uptake, and the effects of exercise. J Magn Res Imaging 2009;30:1130-1138.
-
(2009)
J Magn Res Imaging
, vol.30
, pp. 1130-1138
-
-
Garrood, P.1
Hollingsworth, K.G.2
Eagle, M.3
Aribisala, B.S.4
Birchall, D.5
Bushby, K.6
-
14
-
-
71549145959
-
Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging
-
Kobayashi M, Nakamura A, Hasegawa D, Fujita M, Orima H, Takeda SI. Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging. Muscle Nerve 2009;40:815-826.
-
(2009)
Muscle Nerve
, vol.40
, pp. 815-826
-
-
Kobayashi, M.1
Nakamura, A.2
Hasegawa, D.3
Fujita, M.4
Orima, H.5
Takeda, S.I.6
-
15
-
-
28444498123
-
Noninvasive monitoring of gene correction in dystrophic muscle
-
Walter G, Cordier L, Bloy D, Sweeney HL. Noninvasive monitoring of gene correction in dystrophic muscle. Magn Reson Med 2005;54:1369-1376.
-
(2005)
Magn Reson Med
, vol.54
, pp. 1369-1376
-
-
Walter, G.1
Cordier, L.2
Bloy, D.3
Sweeney, H.L.4
-
16
-
-
14544285197
-
Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging
-
Marden FA, Connolly AM, Siegel MJ, Rubin DA. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skelet Radiol 2005;34:140-148.
-
(2005)
Skelet Radiol
, vol.34
, pp. 140-148
-
-
Marden, F.A.1
Connolly, A.M.2
Siegel, M.J.3
Rubin, D.A.4
|